Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape

被引:4
作者
Patel, Meghana N. [1 ]
Patel, Archita J. [1 ]
Nandpal, Manish N. [1 ]
Raval, Manan A. [1 ]
Patel, Ravish J. [1 ]
Patel, Amit A. [1 ]
Paudel, Keshav Raj [2 ,3 ]
Hansbro, Philip M. [2 ,3 ]
Singh, Sachin Kumar [4 ]
Gupta, Gaurav [5 ,6 ]
Dua, Kamal [7 ]
Patel, Samir G. [1 ]
机构
[1] Charotar Univ Sci & Technol, Ramanbhai Patel Coll Pharm, CHARUSAT Campus,At & Post Changa, Anand 388421, Gujarat, India
[2] Univ Technol Sydney, Centenary Inst, Fac Sci, Ctr Inflammat, Sydney, NSW 2007, Australia
[3] Univ Technol Sydney, Sydney, NSW 2007, Australia
[4] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara, India
[5] Chitkara Univ, Chitkara Coll Pharm, Ctr Res Impact & Outcome, Rajpura 140401, Punjab, India
[6] Ajman Univ, Ctr Med & Bioallied Hlth Sci Res, Ajman, U Arab Emirates
[7] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, Australia
关键词
Drug-Resistant; Tuberculosis; DR-TB Management; AI-Based Approaches; Novel Techniques; Patent Analysis; MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; PYRAZINAMIDE RESISTANCE; RIFAMPICIN RESISTANCE; BANGLADESH REGIMEN; TREATMENT OUTCOMES; MUTATIONS; DIAGNOSIS; GENE; POLYMORPHISMS;
D O I
10.1007/s00210-024-03466-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug-resistant tuberculosis (DR-TB) represents a pressing global health issue, leading to heightened morbidity and mortality. Despite extensive research efforts, the escalation of DR-TB cases underscores the urgent need for enhanced prevention, diagnosis, and treatment strategies. This review delves deep into the molecular and genetic origins of different types of DR-TB, highlighting recent breakthroughs in detection and diagnosis, including Rapid Diagnostic Tests like Xpert Ultra, Whole Genome Sequencing, and AI-based tools along with latest viewpoints on diagnosis and treatment of DR-TB utilizing newer and repurposed drug molecules. Special emphasis is given to the pivotal role of novel drugs and discusses updated treatment regimens endorsed by governing bodies, alongside innovative personalized drug-delivery systems such as nano-carriers, along with an analysis of relevant patents in this area. All the compiled information highlights the inherent challenges of current DR-TB treatments, discussing their complexity, potential side effects, and the socioeconomic strain they impose, particularly in under-resourced regions, emphasizing the cost-effective and accessible solutions. By offering insights, this review aims to serve as a compass for researchers, healthcare practitioners, and policymakers, emphasizing the critical need for ongoing R&D to improve treatments and broaden access to crucial TB interventions.Graphical Abstract- The escalating burden of DR-TB represents a significant global health threat.- Effective strategies are needed for DR-TB's prevention, diagnosis, and treatment.- The review emphasizes DR-TB management with novel techniques and AI approaches.- It also focuses on relevant patents related to DR-TB management.- It underscores continuous research for effective DR-TB control challenges.Graphical Abstract- The escalating burden of DR-TB represents a significant global health threat.- Effective strategies are needed for DR-TB's prevention, diagnosis, and treatment.- The review emphasizes DR-TB management with novel techniques and AI approaches.- It also focuses on relevant patents related to DR-TB management.- It underscores continuous research for effective DR-TB control challenges.Graphical Abstract- The escalating burden of DR-TB represents a significant global health threat.- Effective strategies are needed for DR-TB's prevention, diagnosis, and treatment.- The review emphasizes DR-TB management with novel techniques and AI approaches.- It also focuses on relevant patents related to DR-TB management.- It underscores continuous research for effective DR-TB control challenges.Graphical Abstract- The escalating burden of DR-TB represents a significant global health threat.- Effective strategies are needed for DR-TB's prevention, diagnosis, and treatment.- The review emphasizes DR-TB management with novel techniques and AI approaches.- It also focuses on relevant patents related to DR-TB management.- It underscores continuous research for effective DR-TB control challenges.Graphical Abstract- The escalating burden of DR-TB represents a significant global health threat.- Effective strategies are needed for DR-TB's prevention, diagnosis, and treatment.- The review emphasizes DR-TB management with novel techniques and AI approaches.- It also focuses on relevant patents related to DR-TB management.- It underscores continuous research for effective DR-TB control challenges.
引用
收藏
页码:2127 / 2150
页数:24
相关论文
共 235 条
[1]  
Aaina M, 2021, Journal of Respiration, V2, P1, DOI [10.3390/jor2010001, 10.3390/JOR2010001, DOI 10.3390/JOR2010001, 10.3390/jor2010001]
[2]   Non-Adherence to Anti-Tuberculosis Treatment and Determinant Factors among Patients with Tuberculosis in Northwest Ethiopia [J].
Adane, Akilew Awoke ;
Alene, Kefyalew Addis ;
Koye, Digsu Negese ;
Zeleke, Berihun Megabiaw .
PLOS ONE, 2013, 8 (11)
[3]  
Aggarwal A., 2012, J Dent Educ, DOI [DOI 10.1002/J.0022-0337.2012.76.11.TB05416.X, 10.4103/ijmr.IJMR, DOI 10.4103/IJMR.IJMR]
[4]  
Ahmad Khan F., 2017, Springer, P263, DOI 10.1007/978-1-4939-0694-913
[5]   Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses [J].
Khan, Faiz Ahmad ;
Salim, M. A. Hamid ;
du Cros, Philipp ;
Casas, Esther C. ;
Khamraev, Atajan ;
Sikhondze, Welile ;
Benedetti, Andrea ;
Bastos, Mayara ;
Lan, Zhiyi ;
Jaramillo, Ernesto ;
Falzon, Dennis ;
Menzies, Dick .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (01)
[6]   An updated patent review on drugs for the treatment of tuberculosis (2018-present) [J].
Ahmed, Sarfaraz ;
Nandi, Sisir ;
Saxena, Anil K. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (03) :243-260
[7]   Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis [J].
Alemu, Ayinalem ;
Bitew, Zebenay Workneh ;
Diriba, Getu ;
Gashu, Emebet ;
Seid, Getachew ;
Eshetu, Kirubel ;
Kebede, Abebaw ;
Gumi, Balako .
BMJ OPEN, 2023, 13 (04)
[8]  
Ali Malik Zohaib, 2024, bioRxiv, DOI 10.1101/2023.11.16.567434
[9]  
AllianceGlobal, 2008, GLOBAL ALLIANCE TB D, V88, P85
[10]   Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment [J].
Allue-Guardia, Anna ;
Garcia, Juan I. ;
Torrelles, Jordi B. .
FRONTIERS IN MICROBIOLOGY, 2021, 12